Study In Adults And Adolescents With Seasonal Allergic Rhinitis

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 14 Days in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis

The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as "hay fever", it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.

Inclusion criteria:

• Informed consent.
• Outpatient.
• Females must use appropriate contraception.
• Diagnosis of seasonal allergic rhinitis.
• Adequate exposure to allergen.
• Able to comply with study procedures.
• Literate.

Exclusion criteria:

• Significant concomitant medical condition.
• Use of corticosteroids, allergy medications, or tobacco.
• Clinically significant abnormal ECG.
• Laboratory abnormality.
• Positive pregnancy test.
• Allergy to any component of the investigational product.